|
25 Jun 2019 |
Gilead and Carna Biosciences Announce Research and Development Collaboration to Develop Novel Immuno-Oncology Therapies
|
|
25 Jun 2019 |
Almirall Exercises its Option with Dermira to License Rights to Lebrikizumab in Europe for Atopic Dermatitis
|
|
21 Jun 2019 |
Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis
|
|
20 Jun 2019 |
Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
|
|
20 Jun 2019 |
Gilead and Nurix Establish Strategic Collaboration to Develop Novel Therapies for Cancer and Other Diseases
|
|
20 Jun 2019 |
Amgen And The Institute For Protein Design (IPD) At University Of Washington Announce Unique Strategic Research Partnership
|
|
19 Jun 2019 |
Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine
|
|
17 Jun 2019 |
Voyager Therapeutics Announces Restructured Gene Therapy Relationship with Sanofi Genzyme and Portfolio Update
|
|
17 Jun 2019 |
Intralytix, the Eliava Foundation and Ferring Pharmaceuticals Sign Joint Collaboration Agreement for Reproductive Medicine and Women's Health Initiatives
|
|
17 Jun 2019 |
Pfizer to Acquire Array BioPharma
|
|
13 Jun 2019 |
AbCellera Announces Therapeutic Antibody Discovery Collaboration with Gilead in Infectious Disease
|
|
12 Jun 2019 |
Sobi acquires emapalumab and related assets
|
|
11 Jun 2019 |
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
|
|
11 Jun 2019 |
BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan
|
|
10 Jun 2019 |
Merck to Acquire Tilos Therapeutics
|
|
07 Jun 2019 |
Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics
|
|
03 Jun 2019 |
Vical and Brickell Announce Merger Agreement
|
|
31 May 2019 |
ASLAN Pharmaceuticals Acquires Full Global Commercial Rights for ASLAN004 From CSL
|
|
30 May 2019 |
Amicus Therapeutics and the University of Pennsylvania Announce Major Expansion of Gene Therapy Collaboration
|
|
30 May 2019 |
Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists
|
|
29 May 2019 |
Orchard Therapeutics, Fondazione Telethon and Ospedale San Raffaele Announce Exclusive Worldwide License Agreement for the Treatment of MPS-I
|
|
29 May 2019 |
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
|
|
29 May 2019 |
Ziopharm Oncology Announces Exclusive License with National Cancer Institute to Identify and Use T-Cell Receptors Targeting Neoantigens for Cancer with Sleeping Beauty Platform
|
|
28 May 2019 |
Sensorion Announces the Signature of a Partnership Framework Agreement with Institut Pasteur on Gene Therapy Programs Targeting Hearing Loss
|
|
24 May 2019 |
FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma NovoTTF-100L, a Tumor Treating Fields delivery system, is the first FDA-approved mesothelioma treatment in more than 15 years In
|
